Skip to main content

. 1976 Nov;58(3):434P–435P.

Evolution of aortic and cardiac cyclic AMP phosphodiesterase during the onset of mineralpcorticoid hypertension in the rat [proceedings].

C Lugnier, T Michon, J C Stoclet

PMCID: PMC1667543 PMID: 186145

434P

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Amer M. S. Cyclic nucleotides in disease; on the biochemical etiology of hypertension. Life Sci. 1975 Oct 10;17(7):1021–1038. doi: 10.1016/0024-3205(75)90321-5. [DOI] [PubMed] [Google Scholar]
LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
Lugnier C., Stoclet J. C. Inhibition by papaverine of cGMP and cAMP phosphodiesterases from the rat heart. Biochem Pharmacol. 1974 Nov 1;23(21):3071–3074. doi: 10.1016/0006-2952(74)90285-8. [DOI] [PubMed] [Google Scholar]
Thompson W. J., Appleman M. M. Multiple cyclic nucleotide phosphodiesterase activities from rat brain. Biochemistry. 1971 Jan 19;10(2):311–316. [PubMed] [Google Scholar]

ACTIONS

PDF (258.3 KB)

RESOURCES